Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
81 /100
CRITICAL RISK
Score updated Oct 13, 2026

BIAF — bioAffinity Technologies, Inc. Dilution Risk Tracker

Track BIAF dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BIAF — Get alerts when the score changes →

As of October 13, 2026, bioAffinity Technologies, Inc. (BIAF) has a DilutionWatch DilutionScore of 81/100, rated CRITICAL dilution risk. bioAffinity Technologies, Inc. has a market capitalization of $31.60M, 8.10M shares outstanding, 1 institutional holders tracked. Stored dilution-related fields include 1.83M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
85
📊 Float Risk
55
⚠️ Warrant Exposure
70
🔄 Convertible Debt
15

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 36%
📜 Warrant Exercise model 40%
• Significant warrants: 23% of shares outstanding
• Elevated warrant risk score (70/100)
💰 Capital Raise model 35%
• Low cash runway: 3 months remaining
🔄 Reverse Split model est. 30%
• 52-week low $0.69 has breached $1
• Only 3 months cash — financial pressure
🔔 Track BIAF — Get forecast alerts →

Market Data

Market Cap$31.60M
Shares Outstanding8.10M
Float4.39M
Cash$2.43M
Debt$260.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore81/100DilutionWatch score record
Shares Outstanding8.10MVerified float table or market cache
Public Float4.39MVerified float table or market cache
Market Cap$31.60MMarket data cache
Cash Runway3.3 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants1.83MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 424B5 1, 8-K 3, EFFECT 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 93.6% shares (2026Q1 vs prior)
1 institutional holders · 3.2K shares
#1 BARCLAYS PLC 3.2K shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest115.5K
Days to Cover1.0
% of Float2.6%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-07
xbrl XBRL CONVERTIBLE 2024-04-01
8-K 8K EVENT 2026-10-09
424B5 ATM 2026-10-09
EFFECT EFFECT 2026-09-04
Full SEC filing analysis available with free account →

Recent News

Factual BIAF Dilution Snapshot

bioAffinity Technologies, Inc. (BIAF) has a DilutionScore of 81/100, rated Critical dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

BIAF's DilutionScore is currently 81/100 (Critical risk), with 3 score changes tracked over 89 days. The score deteriorated from 82/100 (Critical risk).

Period Score Risk Level Duration
Oct 01 – Oct 13, 202681/100CRITICAL13 days
Aug 22 – Sep 30, 202682/100CRITICAL40 days
Aug 14 – Aug 21, 202673/100HIGH7 days
Jul 16 – Aug 13, 202679/100CRITICAL29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

BIAF shares outstanding have increased 0.8% from 4.50M (Mar 2026) to 4.53M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 25, 20264.53M4.39M▲ 2.79%
Mar 19, 20264.50M4.27M▲ 0.05%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track BIAF Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment BIAF files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking BIAF — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for BIAF
BIAF FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.